PDL BIOPHARMA, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - February 23, 2015

Attached files

file filename
EX-31.2 - CERTIFICATION - PDL BIOPHARMA, INC.pdli1231201410-kex312.htm
EXCEL - IDEA: XBRL DOCUMENT - PDL BIOPHARMA, INC.Financial_Report.xls
10-K - 10-K - PDL BIOPHARMA, INC.pdli1231201410-kdoc.htm
EX-23.2 - CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PDL BIOPHARMA, INC.pdli1231201410-kex232.htm
EX-32.1 - CERTIFICATION - PDL BIOPHARMA, INC.pdli1231201410-kex321.htm
EX-31.1 - CERTIFICATION - PDL BIOPHARMA, INC.pdli1231201410-kex311.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - PDL BIOPHARMA, INC.pdli1231201410-kex211.htm
EX-12.1 - RATIO OF EARNINGS TO FIXED CHARGES - PDL BIOPHARMA, INC.pdli1231201410-kex121.htm
EX-10.66 - EXCHANGE AGREEMENT BETWEEN TANG CAPITAL PARTNERS, LP AND THE COMPANY - PDL BIOPHARMA, INC.pdli1231201410-kex1066.htm
EX-10.64 - SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT - PDL BIOPHARMA, INC.pdli1231201410-kex1064.htm
EX-10.67 - SUMMARY OF OMITTED AMENDMENTS TO CREDIT AGREEMENT - PDL BIOPHARMA, INC.pdli1231201410-kex1067.htm
EX-10.65 - THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT - PDL BIOPHARMA, INC.pdli1231201410-kex1065.htm


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the following Registration Statements:

(1)     Registration Statement (Form S-3 No. 333-36708) of PDL BioPharma, Inc.,
(2)     Registration Statement (Form S-3 No. 333-122760) of PDL BioPharma, Inc.,
(3)     Registration Statement (Form S-3 No. 333-123958) of PDL BioPharma, Inc.,
(4)     Registration Statement (Form S-3 No. 333-128644) of PDL BioPharma, Inc.,
(5)     Registration Statement (Form S-3ASR No. 333-174052) of PDL BioPharma, Inc.,
(6)     Registration Statement (Form S-8 No. 333-87957) pertaining to the 1999 Stock Option Plan and 1999
Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,
(7)     Registration Statement (Form S-8 No. 333-68314) pertaining to the 1999 Stock Option Plan and 1999
Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,
(8)
Registration Statement (Form S-8 No. 333-104170) pertaining to the 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,
(9)     Registration Statement (Form S-8 No. 333-125906) pertaining to the 2005 Equity Incentive Plan of PDL
BioPharma, Inc., and
(10)     Registration Statement (Form S-8 No. 333-145262) pertaining to the 2005 Equity Incentive Plan of PDL
BioPharma, Inc.

of our report dated February 23, 2015, relating to the consolidated financial statements of PDL Bio Pharma, Inc., and the effectiveness of internal control over financial reporting of PDL BioPharma, Inc., which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP

San Jose, California
February 23, 2015



PDL BIOPHARMA, INC. Reports